戻る Agenda
GVP Module Product - Or Population - Specific Considerations III: Pregnant and Breastfeeding Women
Speaker(s)
GVP MODULE PRODUCT - OR POPULATION-SPECIFIC CONSIDERATIONS III: PREGNANT AND BREASTFEEDING WOMEN
Hedvig Marie Egeland Nordeng
University of Oslo, Norway
PRAC Member, Independent Scientific Expert (nominated by EC)
THE IMI CONCEPTION CONSORTIUM: ECOSYSTEM FOR EVIDENCE ON THE SAFETY OF MEDICINES IN PREGNANCY & BREASTFEEDING
David John Lewis, PHD
Novartis Pharma Gmbh, Switzerland
Former Head QPPV PRRC Office, Patient Safety & Pharmacovigilance
Q&A AND PANEL DISCUSSION INCLUDING:
Adrien Inoubli
Agence nationale de sécurité du médicament et des produits de santé (ANSM), France
Q&A AND PANEL DISCUSSION INCLUDING:
Ulla Wändel Liminga, DrMed, MS, RPH
Medical Products Agency (MPA), Sweden
Scientific Director Pharmacology/Toxicology